Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.
A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.
Using the technology, scientists have revealed that cell division isn’t necessarily the main cause of genetic changes in human tissue DNA.
Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year.
Responsible for setting the Charity’s strategic direction, Cancer Research UK’s Council of Trustees plays a vital role in setting the organisation’s agenda.
Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.
Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.